Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Alliance Submits Comments to CMS on “CRUSH” Regulation RFI March 30, 2026
Alliance of Specialty Medicine Submits Comments on MAPD Advance Notice February 20, 2026
Alliance Newsletter: On Call Winter 2026 February 9, 2026
Alliance of Specialty Medicine Comments on CY 2027 MA and Part D Proposed Rule January 26, 2026© 2026 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

